Class II

Drug Recall: GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

GE Healthcare Ireland Limited · March 24, 2026

Reason for Recall

Presence of particulate matter

Distribution

U.S. Nationwide.

States Affected

NATIONWIDE

Quantity Affected

866,570 vials

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0447-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.